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Percutaneous techniques for aneurysm repair
Mark D. Morasch, MD, Chicago, IllINTRODUCTION
All of the devices developed to date for endograft repair
of abdominal (AAA) and thoracic (TAA) aortic aneurysms
are deployed through relatively large (12F to 24F) sheaths
and must be positioned appropriately within the aorta after
the sheaths are passed through access sites in the common
femoral or iliac vessels. Traditionally, and with few excep-
tions, this access has required arterial exposure via cutdown
skin incisions; the sheaths are passed through an open
arteriotomy after vascular clamps are applied to control the
vessels. In general, this process is safe, but it does require
practitioners experienced in open surgical technique, and
in many institutions, cutdown mandates operating room
availability and general or spinal anesthesia. In addition,
open arterial access does have a well-defined set of potential
complications.
With smaller access sheath sizes and with the develop-
ment of suture-mediated arterial closure devices, com-
pletely percutaneous treatment of both AAA and TAA is
now feasible. Potential advantages to percutaneous endograft
deployment include shorter procedure time, improved pa-
tient acceptance, earlier ambulation, and reduced risk for
wound complications.1-4 Percutaneous sheath placement
has its own unique set of risks, and practitioners must be
comfortable with the technique for the benefits to out-
weigh these risks. This technique requires familiarity with
off-label use of suture-mediated closure devices. In addi-
tion, percutaneous approaches are facilitated by the use of
endografts that can be deployed with short procedure times
and through relatively small introducer sheaths.5
TECHNICAL CONSIDERATIONS
Preoperative selection. Thin collimation computed
tomography (CT) with three-dimensional reconstruction
provides all the information necessary to determine ana-
tomic suitability for percutaneous endovascular aneurysm
repair (EVAR). Appropriate device lengths and diameters
can be selected on the basis of reconstructed CT data. In
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aortic accessibility through the iliac vessels can be derived from
CT images. We pay specific attention to iliofemoral artery
diameters, to vessel tortuosity and degree of calcification, and
to the specific location of the femoral bifurcation.
Detailed techniques. General or spinal anesthesia is
induced or local anesthesia is infiltrated into the skin and
expected tract of the introducers. The skin is clipped before
the procedure and the patients are prepared and draped to
provide adequate exposure to the abdomen, retroperito-
neum, and groins for potential surgical cutdown.We use an
adhesive, antiseptic-impregnated drape over the prepared,
exposed skin areas.
Percutaneous access is performed through small stab
incisions. Arterial access is initiated with an 18-gauge nee-
dle. Care is taken to puncture the common femoral artery
by first fluoroscopically imaging the femoral joint or by
insonating the vessel. It is essential that anterior puncture of
the common femoral artery be performed and verified.
Proximal punctures into the external iliac through fibers of
the inguinal ligament are less likely to be hemostatic; more
distal access through the deep or superficial femoral vessels
is likely to result in vascular occlusion. Puncture location is
routinely confirmed by sheath injection arteriography with
an ipsilateral oblique view before proceeding further.
A standard J wire is positioned in the aorta and a short
6F or 8F sheath is placed to pre-dilate the access site. After
a tract is cleared through the superficial soft tissue down to
the artery, using a hemostat or a finger, the sheath is then
exchanged for a single, monorail, 10F Prostar XL device
(Perclose, an Abbott Laboratory Company, RedwoodCity,
Calif). Because the device delivery sheaths are all signifi-
cantly larger (12F to 24F) than the 10F closure system,
the two Perclose sutures are placed before the arteriotomy
is enlarged by the endograft deployment sheaths—the
“preclose” technique.
It helps to irrigate the three P tubes with heparinized
saline before the shaft of the closure apparatus is intro-
duced. Only after blood return is brisk through all three P
tubes should the deployment ring be cocked and pulled.
After confirmation of arterial flow through the marker
lumen, the barrel is aligned and the ring withdrawn. The
proper amount of tension is maintained on the shaft so that
the artery is not compressed when the needles are deployed.
This will ensure that the sutures will be placed adjacent to
the arteriotomy and only in the anterior arterial wall. If
there is significant resistance to deploying the needles,
which usually indicates that the needles have not entered
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may be performed and the device readjusted or exchanged.
The two Perclose 3-0 braided polyester sutures (one
device) are deployed through the artery wall when the ring
is pulled back completely. The needles are removed from
the back end of the Perclose housing and each needle is cut
from the suture. The closure device is partially withdrawn
from the artery and the four suture ends are retrieved. The
two Perclose sutures (four suture ends) are left, untied, to
rest upon the patient in radial orientation until after the
endograft deployment has been completed (Fig). Amplatz
guidewire access is regained through the monorail side port
on the shaft of the closure device. An 18-gauge entry needle
facilitates this maneuver. At this point, a second closure
device can be used to deploy two more sutures for longer
sheaths. Patients are administered a small dose (1K units) of
intravenous unfractionated heparin, and the endograft de-
livery sheaths then are passed into the aorta over a stiff wire
and through the untied sutures.
Once the thoracic endograft has been deployed com-
pletely and with satisfaction, and after completion arteriog-
raphy has been reviewed and found to be acceptable, the
sheaths are removed. The sutures should be generously
soaked with heparinized saline and wiped free of any
thrombus; they are tied with a slipknot or a standard
surgeon’s knot while an assistant maintains proximal man-
ual pressure. The sutures are trimmed as short as possible.
Often, a brief period of compression is required to stop
suture hole bleeding. The small stab incision is closed with
a single subcutaneous suture, a subcuticular stitch, and a
Steri-Strip (3M, St. Paul, Minn).
The Sutura SuperStitch (Sutura, Inc, Fountain Valley,
Calif) is an 8F single-suture arterial closure system designed
for treating up to 10F sheath punctures.Off-label large sheath
closure has been reported with this single-stitch device. The
company has double and triple suture closure systems in
development, based on similar core technology, that have
Deployed sutures.been designed for arterial closure with up to a 24F sheath.DISCUSSION
Endovascular treatment of infrarenal AAAs has become
commonplace. Thoracic endografts are not far behind.
These industry-manufactured thoracic devices are presently
being used to treat aneurysms, dissections, and traumatic
transections in the United States. One device has been
approved for treatment of aneurysms in the United States
and at least three more are presently in trials. These same
devices have been available in European markets for some
time now. Early results suggest that advantages to endolu-
minal repair of thoracic aortic pathology will be equal to or
greater than those for AAAs.
Complete percutaneous repair of thoracic aortic pa-
thology is feasible. The advantages of complete percutane-
ous endograft deployment are small but real compared with
device deployment through open femoral cutdowns. Per-
cutaneous aortic repair requires special expertise and prac-
titioners must become familiar with particular arterial clo-
sure devices before they abandon open access.
Suture-mediated closure devices such as Prostar XL can
be used off-label to repair the defect that remains after
removal of the larger sheaths used during endovascular
aortic therapies.1,2,6 Deployment of one or two of these
devices per femoral artery provides for safe and secure
arterial closure through a simple stab incision in the groin.
Different strategies for percutaneous repair may be
necessary, depending on the experience of the team and on
the availability of facilities necessary for immediate open
cutdown, if this were to become necessary. Presently we
consider most of our thoracic endovascular candidates for
treatment with percutaneous techniques. We convert im-
mediately to an open cutdown if bleeding, stenosis, or
femoral artery injury is an issue. This is feasible because we
have access to excellent fixed imaging in a sterile operating
room. We avoid percutaneous treatment for patients with
small, calcified, or aneurysmal femoral vessels, patients with
previous femoral dissection or history of prior use of a
closure device, and patients with inaccessible iliacs. We
found that obese patients can be particularly challenging
but that it is this patient population that has the most to
gain from avoiding a larger incision. A conservative selec-
tive approach should certainly be used during the initial
percutaneous learning curve and when preferred imaging
and an operating room environment are not present in the
same location.
We began our percutaneous EVAR experience by using
the suture-mediated closure devices on arteries that were
fully exposed surgically. This step develops visual familiar-
ization with the devices’ mechanisms, anticipated prob-
lems, and the expected resistance during each of the de-
ployment steps. After achieving technical proficiency with
the devices, reducing the levels of anticoagulation, and
insisting on anterior common femoral artery puncture,
complications have become extremely rare and percutane-
ous thoracic aortic repair has become a routine option.
There are both real and theoretical advantages to
percutaneous therapy. In an earlier review of AAA pa-
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cutaneous access were compared with 35 patients with
femoral cutdown. Patients who underwent percutaneous
endograft deployment had more rapid repair, and we were
able to treat more patients with local or regional anesthesia
rather than a general anesthetic. Intraoperative conversion
to cutdown occurred in 15% of these patients. Patients
were able to ambulate immediately after the procedure and
had short recovery times. Wound complications after hos-
pital discharge, including infection, femoral neuropathy,
and complications arising from lymphatic disruption, were
not uncommon after open cutdown. In our initial experi-
ence, such late complications were nonexistent after percu-
taneous treatment.7 We have now completed nearly 200
complete percutaneous infrarenal aneurysm repairs and 20
thoracic repairs. Although we have had two late pseudoan-
eurysms arise after patient discharge, our overall incidence
of complication has dropped 8%.
Despite these reasonable results, caution is warranted
because significant complications may occur. Device en-
trapment, acute arterial thrombosis with limb ischemia,
arterial injury, suture breaks resulting in hemorrhage, arte-
rial dissection, suture infection, and pseudoaneurysm or
arteriovenous fistula formation have all been described after
use of this closure technique.3-5,8-14 We have found that it
is particularly important that the common femoral be the
artery of choice for access. If the external iliac artery is punc-
tured through the inguinal ligament, the suture-mediated
closure device will not deploy properly, and early or late
complications are likely to occur. Access distal to the com-
mon femoral artery can also be problematic. When punc-
tures involve the superficial or deep femoral vessels, suture-
mediated closure can result in vessel occlusion and acute
limb ischemia.
As with open cutdown, clinicians need to closely mon-
itor for arterial occlusion and hemorrhage. Bleeding com-
plications and acute arterial occlusion should be recognized
early. These complications can be substantial, and they
often require treatment with surgical exposure of the ac-
cessed artery immediately, before the patient is taken from
the operating suite. In our published review of AAA pa-
tients, 7% experienced immediate access site complications
that required urgent surgical attention.7 We have experi-
enced just one access complication in the 20 patients treated
percutaneously with thoracic devices. This patient devel-
oped a significant retroperitoneal bleed on the side of the
6F puncture contralateral to the large sheath insertion site.
To date, we have experienced no significant adverse
events directly related to the large sheath percutaneous
insertion site. These complications are easily addressed
when they are identified in the operating suite. As a corol-
lary, we continue to recommend that complete percutane-
ous aortic repair be performed by surgeons and in an
operating room. Alternatively, percutaneous therapy can be
undertaken in a cardiac catheterization lab or an interven-
tional radiology suite, when both a surgeon and an operat-
ing room are on standby for immediate assistance and
transfer if problems arise.Presently, we consider all AAA and nearly all thoracic
endograft patients to be candidates for percutaneous repair.
Although patients with very small, severely calcified, or
aneurysmal iliac or femoral arteries must be approached
with caution, and clearly any patient who requires a pros-
thetic chimney conduit to gain aortic access needs open
arterial exposure, many patients can safely be treated per-
cutaneously with great success.
CONCLUSION
Newer endograft technology has made complete per-
cutaneous treatment of AAA and thoracic aortic pathology
feasible in most patients. Elements of success include an
appropriate strategy for arterial access, familiarity with the
technical nuances of the closure system, and the use of
endoprostheses with predictably short procedure times and
smaller access sheaths. Percutaneous treatment of aortic
diseases should initially be reserved for carefully selected
patients and should be performed in a sterile environment
or where open arterial access can be obtained rapidly, if
required.
Percutaneous access does have some advantages over
open femoral artery cutdown, but percutaneous approaches
to endovascular aortic repair are not free of risk. Once a sig-
nificant amount of experience has been gained and the prac-
titioner becomes comfortable with the specific techniques,
most patients can be considered for percutaneous repair.
Furthermore, greater benefits are expected as improved
percutaneous techniques and newer suture-mediated clo-
sure devices, including those specifically designed for large
vessel closure, are developed.
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